Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Lung Neoplasms

Ependymoma, Glioblastoma, Central Nervous System Neoplasms

Prostate Adenocarcinoma

Pathologic Complete Response

Anus Neoplasms

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

Neuroendocrine Tumors

Oropharyngeal Neoplasms

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Mesothelioma, Malignant

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Estrogen Receptor Positive

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Glioblastoma

Prostatic Neoplasms

Breast Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Lymphoma, B-Cell, Marginal Zone

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Hepatocellular, Cholangiocarcinoma

Salivary Gland Neoplasms

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Hodgkin Disease, Neoplasms

Prostatic Neoplasms

Glioblastoma, Glioma

Prostatic Neoplasms

Glioblastoma

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Glioblastoma, Gliosarcoma

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

Clinical Trials

Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies

PNOC023

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

MEND-IT II

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

(NeoScorch HN)

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

DEBRA

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

MelPORT

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas